GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
H

Hangzhou Tigermed Consulting Co 300347.SZ · CNY

Health Care · Shenzhen · 🇨🇳 China

Compare

51.27

-0.66%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Analyst ratings

18 analysts, 1 Mar 2026. The analysts' own views, not ours.

  • 3Strong buy
  • 10Buy
  • 3Hold
  • 2Sell
  • 0Strong sell

Price targets

Brokers' own targets, 21 Feb 2026. Not our view.

Last close 51.27Average target 69.36

Low
40.40
Average
69.36
Median
75.45
High
90.30

Forecasts

Analyst averages for the fiscal years ahead

FY2026FY2027FY2028FY2029FY2030
RevenueCN¥7.78bnCN¥8.99bnCN¥10.45bnCN¥10.86bnCN¥12.07bn
Revenue, highestCN¥7.99bnCN¥9.54bnCN¥11.46bnCN¥11.49bnCN¥12.77bn
Revenue, lowestCN¥7.63bnCN¥8.35bnCN¥9.18bnCN¥10.17bnCN¥11.30bn
Earnings per share0.501.331.82——
Earnings per share, highest0.511.332.24——
Earnings per share, lowest0.461.221.28——
Analysts111312106

Earnings against forecasts

Earnings per share by fiscal quarter

Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Forecast0.320.140.260.170.340.350.270.53
Reported0.17-0.530.06-0.150.740.260.19-0.47
Difference-47.6%-477.7%-77.2%-190.0%+115.1%-26.4%-29.0%-189.3%

Quality and value scores

Models run by our data supplier, not our view and not investment advice

Model

Quality score

5 / 10

Revenue growth 21.7% a year over 10 years. Return on equity 4.2%.

Model fair value

48.78

From earnings 48.78, from revenue 60.09.

Piotroski score

3 / 9

A nine-point test of financial strength, for 31 Dec 2024.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.